Insmed
INSM
230 hedge funds and large institutions have $2.48B invested in Insmed in 2023 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 88 increasing their positions, 72 reducing their positions, and 28 closing their positions.
36% more call options, than puts
Call options by funds: $9.64M | Put options by funds: $7.08M
22% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 72
21% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 28
2% more funds holding
Funds holding: 225 → 230 (+5)
0.78% more ownership
Funds ownership: 105.88% → 106.66% (+0.78%)
13% less capital invested
Capital invested by funds: $2.86B → $2.48B (-$384M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$43.4M |
| 2 |
Bank of New York Mellon
New York
|
+$22.1M |
| 3 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$9.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.45M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$9.42M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$25.8M |
| 2 |
BlackRock
New York
|
-$19.9M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$19.3M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$13.7M |
| 5 |
State Street
Boston,
Massachusetts
|
-$10.9M |
INSM Hedge Fund Activity: Q1 2023 in Review
230 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q1 2023, worth a combined $2.48B — down 13% from $2.86B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new INSM positions and 28 closed out — a net gain of 6 holders — while 88 added to existing stakes and 72 trimmed.
The largest buyer was Deep Track Capital, adding an estimated $43.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $25.8M sold.
- 230 institutional investors held Insmed (INSM) as of Q1 2023, up from 225 in Q4 2022.
- Funds reported $2.48B of Insmed stock for Q1 2023, down 13% quarter-over-quarter.
- 34 funds opened new Insmed positions in Q1 2023 and 28 closed out, a net change of +6 holders.
- The largest Insmed buyer in Q1 2023 was Deep Track Capital, an estimated $43.4M added.
- The largest Insmed seller in Q1 2023 was Point72 Asset Management, an estimated $25.8M sold.
Based on aggregated 13F filings for Q1 2023.